The Anti-SSA (Ro) IgG ELISA test is a blood test used to detect antibodies against the SSA/Ro antigen, which are strongly associated with autoimmune conditions such as Sjögren’s syndrome and systemic lupus erythematosus. This test is important because it helps confirm suspected autoimmune disorders, especially in patients with symptoms like dry eyes, dry mouth, or unexplained fatigue. By identifying these specific antibodies, the test supports accurate diagnosis, guides treatment planning, and assists in monitoring disease progression for better patient management.
It helps confirm autoimmune conditions by identifying specific antibodies, guiding diagnosis and treatment planning.
Patients with symptoms such as dry eyes, dry mouth, fatigue, or suspected autoimmune disorders are recommended for testing.
A positive result suggests autoimmune activity, often linked to Sjögren’s syndrome or lupus, requiring further evaluation.
A negative result indicates no detectable anti-SSA antibodies, though autoimmune disease cannot be completely ruled out.
Certain medications may influence antibody levels, potentially affecting accuracy.
Without testing, autoimmune diseases may remain undiagnosed, leading to progressive organ damage.
They cannot be fully prevented, but early detection and treatment reduce complications.
Positive results are associated with Sjögren’s syndrome, systemic lupus erythematosus, and other connective tissue diseases.
...
Didn't recieved OTP Yet? Resend OTP